Ameliorative effects of amide derivatives of 1,3,4-thiadiazoles on scopolamine induced cognitive dysfunction
Authors:
- 1 October 2016
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 122, 557-573
Abstract
No abstract availableKeywords
Funding Information
- Council of Scientific and Industrial Research (02/(0107)/12-EMR-II)
This publication has 32 references indexed in Scilit:
- Acetylcholinesterase Inhibitors: Pharmacology and ToxicologyCurrent Neuropharmacology, 2013
- What do we know about aging and spatial cognition? Reviews and perspectivesAgeing Research Reviews, 2012
- Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s DiseasesMolecular Medicine, 2008
- Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's diseaseNeuroscience Letters, 2005
- Design of New Cognition Enhancers: From Computer Prediction to Synthesis and Biological EvaluationJournal of Medicinal Chemistry, 2004
- Non-Cholinergic Pharmacotherapy Approaches to the Future Treatment of Alzheimers DiseaseMini-Reviews in Medicinal Chemistry, 2002
- The Molecular Bases of Alzheimer's Disease and Other Neurodegenerative DisordersArchives of Medical Research, 2001
- Cholinergic Markers in Elderly Patients With Early Signs of Alzheimer DiseaseJAMA, 1999
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIESBrain, 1976